Optimizing antiresorptive treatment in patients with bone metastases: time to initiation, switching strategies, and treatment duration
出版年份 2019 全文链接
标题
Optimizing antiresorptive treatment in patients with bone metastases: time to initiation, switching strategies, and treatment duration
作者
关键词
Bisphosphonate, Denosumab, Treatment initiation, Duration, Switching
出版物
SUPPORTIVE CARE IN CANCER
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2019-02-14
DOI
10.1007/s00520-019-04676-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Denosumab versus bisphosphonates in patients with advanced cancers-related bone metastasis: systematic review and meta-analysis of randomized controlled trials
- (2018) Amr Menshawy et al. SUPPORTIVE CARE IN CANCER
- Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases
- (2017) Andrew L. Himelstein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Aggressive End-of-Life Care for Metastatic Cancer Patients Younger Than Age 65 Years
- (2017) Aaron D Falchook et al. JNCI-Journal of the National Cancer Institute
- Aggressive End-of-Life Care for Metastatic Cancer Patients Younger Than Age 65 Years
- (2017) Aaron D Falchook et al. JNCI-Journal of the National Cancer Institute
- Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone
- (2017) Gabriel N. Hortobagyi et al. JAMA Oncology
- NCCN Task Force Report: Bone Health in Cancer Care
- (2017) Julie R. Gralow et al. Journal of the National Comprehensive Cancer Network
- Evidence on the analgesic role of bisphosphonates and denosumab in the treatment of pain due to bone metastases: A systematic review within the European Association for Palliative Care guidelines project
- (2016) Josep Porta-Sales et al. PALLIATIVE MEDICINE
- Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer?
- (2016) L E Howard et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Use of the landmark method to address immortal person-time bias in comparative effectiveness research: a simulation study
- (2016) Xiaojuan Mi et al. STATISTICS IN MEDICINE
- Trends in end-of-life cancer care in the Medicare program
- (2016) Shi-Yi Wang et al. Journal of Geriatric Oncology
- Bisphosphonates in the Treatment of Patients With Metastatic Breast, Lung, and Prostate Cancer
- (2015) Jing Liu et al. MEDICINE
- Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer
- (2015) Alison T. Stopeck et al. SUPPORTIVE CARE IN CANCER
- Bone health in cancer patients: ESMO Clinical Practice Guidelines
- (2014) R. Coleman et al. ANNALS OF ONCOLOGY
- Bone metastasis, skeletal-related events, and mortality in lung cancer patients: A Danish population-based cohort study
- (2014) Karynsa Cetin et al. LUNG CANCER
- Precision Oncology in Breast Cancer: Better than Ever, or Less than Before?
- (2013) Adam Brufsky Breast Journal
- Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial
- (2013) Dino Amadori et al. LANCET ONCOLOGY
- Prospective observational study of treatment pattern, effectiveness and safety of zoledronic acid therapy beyond 24 months in patients with multiple myeloma or bone metastases from solid tumors
- (2013) T. Van den Wyngaert et al. SUPPORTIVE CARE IN CANCER
- Cost of skeletal-related events in European patients with solid tumours and bone metastases: data from a prospective multinational observational study
- (2013) G. Hechmati et al. JOURNAL OF MEDICAL ECONOMICS
- Prolonged administration of bisphosphonates is well-tolerated and effective for skeletal-related events in Chinese breast cancer patients with bone metastasis
- (2012) Xiaoyan Ding et al. BREAST
- Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis
- (2012) Maria A. Lopez-Olivo et al. SUPPORTIVE CARE IN CANCER
- Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999–2007)
- (2011) Mellissa Yong et al. BREAST CANCER RESEARCH AND TREATMENT
- American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer
- (2011) Catherine H. Van Poznak et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates
- (2009) Karim Fizazi et al. JOURNAL OF CLINICAL ONCOLOGY
- Denosumab Treatment of Prostate Cancer With Bone Metastases and Increased Urine N-Telopeptide Levels After Therapy With Intravenous Bisphosphonates: Results of a Randomized Phase II Trial
- (2009) Karim Fizazi et al. JOURNAL OF UROLOGY
- Impact of skeletal complications on patients’ quality of life, mobility, and functional independence
- (2008) Luis Costa et al. SUPPORTIVE CARE IN CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now